Skip to main content
OpenTrials

Clinical trial condition

Glomerulonephritis

Explore clinical trials studying Glomerulonephritis. Study availability and eligibility vary by location and protocol.

26 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Glomerulonephritis trial results

Recruiting

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

NCT04663204

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, England, United Kingdom
  • Northern Care Alliance NHS Foundation Trust - Salford Royal Salford, England, United Kingdom
  • Royal Infirmary of Edinburgh & Western General Hospital Edinburgh, Scotland, United Kingdom
  • University Hospital of wales Cardiff, Wales, United Kingdom
View Trial Details
Completed

TESTING -ON Post-Trial ObservatioNal Cohort Study

NCT05434325

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +17 more
Locations
  • Concord Repatriation General Hospital Concord W., New South Wales, Australia
  • Nepean Hospital Kingswood, New South Wales, Australia
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 59 locations
View Trial Details
Completed

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy

NCT05174221

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Glomerulonephritis, +6 more
Locations
  • Amicis Research Center - Northridge - Nordhoff Northridge, California, United States
  • Boise Kidney and Hypertension Institute - Frenova Nampa, Idaho, United States
  • NorthShore University HealthSystem Evanston, Illinois, United States
  • Core Research Group Milton, Queensland, Australia
View all 26 locations
View Trial Details
Completed

Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE)

NCT04733040

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Managadze National Center of Urology Tbilisi, Georgia
  • Tbilisi State Medical University and Ingorokva High Medical Technology University Clinic Tbilisi, Georgia
  • University Hospital Aachen Aachen, Germany
  • Charite Berlin, Germany
View all 25 locations
View Trial Details

Related conditions